F
Freddie Bray
Researcher at International Agency for Research on Cancer
Publications - 452
Citations - 345102
Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.
Papers
More filters
Journal ArticleDOI
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020
Citadel J Cabasag,Paula J Fagan,Jacques Ferlay,Jérôme Vignat,Mathieu Laversanne,Lihua Liu,Maaike A. van der Aa,Freddie Bray,Isabelle Soerjomataram +8 more
TL;DR: The study highlights the disproportionate current and future burden of ovarian cancer in countries with lower HDI levels, calling for global action to reduce the burden and inequality of ovarian cancer in access to quality cancer care and treatment.
Journal ArticleDOI
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014
Eileen Morgan,Isabelle Soerjomataram,Anna Gavin,Mark J. Rutherford,Piers A.C. Gatenby,Aude Bardot,Jacques Ferlay,Oliver Bucher,Prithwish De,Gerda Engholm,Christopher Jackson,Serena Kozie,Alana Little,Bjørn Møller,Lorraine Shack,Hanna E. Tervonen,Vicky Thursfield,Sally Vernon,Paul M. Walsh,Ryan Woods,Christian Finley,Neil D. Merrett,Dianne L. O'Connell,John V. Reynolds,Freddie Bray,Melina Arnold +25 more
TL;DR: Marked improvements in both oesophageal AC and SCC survival suggest advances in treatment, and the need for further advances in early detection and treatment of oesophileal cancer alongside primary prevention to reduce the overall burden from the disease.
Journal ArticleDOI
Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007.
TL;DR: The incidence and mortality for pancreatic cancer remain largely unchanged, with few 5-year survivors, but a modest improvement in short-term survival has been noted, with 1-year survival rates of 18% and 16% for males and females, respectively.
Journal ArticleDOI
Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States.
Melina Arnold,Heinz Freisling,Rachael Z. Stolzenberg-Solomon,Frank Kee,Mark G. O'Doherty,José M Ordóñez-Mena,José M Ordóñez-Mena,Tom Wilsgaard,Anne Maria May,H. B. Bueno-De-Mesquita,Anne Tjønneland,Philippos Orfanos,Antonia Trichopoulou,Paolo Boffetta,Freddie Bray,Mazda Jenab,Isabelle Soerjomataram +16 more
TL;DR: Risks associated with a longer overweight duration were higher in men than in women and were attenuated by smoking, and increased risks were confined to women who never used hormone therapy.
Journal ArticleDOI
Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964–2003 followed up until the end of 2006
Freddie Bray,Gerda Engholm,Timo Hakulinen,Mette Gislum,Laufey Tryggvadottir,Hans H. Storm,Åsa Klint +6 more
TL;DR: Time-varying proportions of the major histological subtypes might however have affected the survival estimates for a number of the cancer forms reviewed here, including brain cancer, which has been rising but mortality has been relatively stable.